SCHEMBL21332385

SCHEMBL21332385

O=C(O)N1CC=C(c2ncnc3cc(Cl)cnc23)CC1

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 8/20 0.43
LIMK2 P53671 8/20 0.43
KIT P10721 4/20 0.41
TRPV1 Q8NER1 8/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21339753 0.84 KIT (0.46) KIT
SCHEMBL21339637 0.83 KIT (0.42) LIMK1LIMK2KIT
SCHEMBL27929255 0.78 TRPV1 (0.41) LIMK1LIMK2TRPV1
SCHEMBL22899639 0.73 DRD4 (0.34) KIT
SCHEMBL2636728 0.71 NAMPT (0.46)
SCHEMBL21994832 0.71 CNR1 (0.43)
SCHEMBL23235670 0.71 ALDH1A1 (0.43) TRPV1
SCHEMBL21332342 0.70 KIT (0.46) KIT
SCHEMBL16793728 0.70 CCNT1 (0.39)
SCHEMBL2266251 0.69 ALDH1A1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3762379-A1 IDENTIFICATION AND USE OF ERK5 INHIBITORS Bayer Aktiengesellschaft (DE) 2021-01-13 EP disclosed
WO-2019170543-A1 IDENTIFICATION AND USE OF ERK5 INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2019-09-12 WO disclosed